Salivary steroids in response to ACTH: A less invasive approach to assess adrenal function in hypotensive patients with chronic renal failure

Endocrinologist

Volumn 16, Issue 1, 2006, Pages 30-35

  Contreras, Liliana N ^a   Arregger, Alejandro L ^a   Tumilasci, Omar ^b   Persi, Gabriel ^a   Zucchini, Alfredo ^a   Cardoso, Estela M ^a  

^a INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

ACTH test; Chronic renal failure; Hypotension; Salivary steroids

Indexed keywords

CORTICOTROPIN; STEROID;

ADRENAL FUNCTION; ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DIAGNOSTIC ACCURACY; FEMALE; FLOW RATE; HIGH RISK PATIENT; HUMAN; HYPOALDOSTERONISM; HYPOTENSION; KIDNEY FAILURE; MALE; MEASUREMENT; SALIVA ANALYSIS; SAMPLING;

EID: 33748631023     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ten.0000194248.85361.bf     Document Type: Article

References (48)

1. Wood JB, James VHT, Frankland AW, et al. A rapid test of adrenocortical function. Lancet. 1965;1:243-245.
2. Speckart PF, Nicoloff JT, Bethune JE. Screening for adrenocortical insufficiency with cosyntropin (synthetic ACTH). Arch Intern Med. 1971;128:761-763.
3. Dluhy RG, Himathongkam T, Greenfield M. Rapid ACTH test with plasma aldosterone levels. Ann Intern Med. 1974;80:693-696.
4. Weidmann P, Reinhart R, Maxwell MH, et al. Syndrome of hyporeninemic hypoaldosteronism and hyperkalemia in renal disease. J Clin Endocrinol Metab. 1973;36:965-977.
5. Oh MS, Carroll HJ, Clemmons JE, et al. A mechanism for hyporeninemic hypoaldosteronism in chronic renal disease. Metabolism. 1974;23:1157-1165.
6. Barbour GL, Sevier BR. Adrenal responsiveness in chronic hemodialysis. N Engl J Med. 1974;290:1258.
7. McDonald WJ, Golper TA, Mass RD, et al. Adrenocorticotropin-cortisol axis abnormalities in hemodialysis patients. J Clin Endocrinol Metab. 1979;48:92-95.
8. Siang TY, Burton M. Hyporeninemic hypoaldosteronism. Arch Intern Med. 1981;141:30-33.
9. Ramirez G, Gomez-Sanchez C, Meikle WA, et al. Evaluation of the hypothalamic hypophyseal adrenal axis in patients receiving long-term hemodialysis. Arch Intern Med. 1982;42:1448-1452.
10. Grekas D, Tourkantonis A, Pharmakiotis A. Adrenal responsiveness during and after intermittent haemodialysis. Clin Exp Dial Apheresis. 1983;7:197-205.
11. Vigna L, Buccianti G, Orsatti A, et al. The impact of long-term hemodialysis on pituitary-adrenocortical function. Ren Fail. 1995;17:629-637.
12. Clodi M, Riedl M, Schmaldienst S, et al. Adrenal function in patients with chronic renal failure. Am J Kidney Dis. 1998;32:52-55.
13. Gmar-Bouraoui S, Achour A, Abbes M, et al. Adrenocortical insufficiency in renal amyloidosis. Ann Endocrinol (Paris). 2001;62:4-6.
14. Harvey CJ, Gower PE, Hawkins PN, et al. Occult adrenal insufficiency secondary to amyloidosis in the context of chronic renal failure. Nephrol Dial Transplant. 1995;10:1237-1239.
15. Riad-Fahmy D, Read GF, Walker RF, et al. Steroids in saliva for assessing endocrine function. Endocr Rev. 1982;3:367-395.
16. Raff H. Salivary cortisol: a useful measurement in the diagnosis of Cushing's syndrome and the evaluation of the hypothalamic-pituitary adrenal-axis. Endocrinologist. 2000;10:9-17.
17. Cardoso E, Persi G, Arregger AL, et al. Assessment of corticoadrenal reserve through salivary steroids. Endocrinologist. 2002;12:38-44.
18. Hörl MP, Hörl WH. Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis. 2002;39:227-244.
19. Cases A, Coll E. Chronic hypotension in the dialysis patient. J Nephrol. 2002;15:331-335.
20. Passauer J, Büssemaker E, Gross P. Dialysis hypotension: do we see light at the end of the tunnel? Nephrol Dial Transplant. 1998;13:3024-3029.
21. Mazzuchi N, Schwedt E, Fernández, et al. Latin American registry of dialysis and renal transplantation: 1993 annual dialysis data report. Nephrol Dial Transplant. 1997;12:2521-2527.
22. Perazella MA. Pharmacologic options available to treat symptomatic intradialytic hypotension. Am J Kidney Dis. 2001;38(suppl 4):S26-S36.
23. Daugirdas JT. Dialysis hypotension: a hemodynamic analysis. Kidney Int. 1991;39:233-246.
24. Daugirdas JT. Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis. 2001;38(suppl 4):S11-S17.
25. Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill. A new look at an old problem. Chest. 2002;122:1784-1796.
26. Yang S, Zhang L. Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol. 2004;2:1-12.
27. Rudolph AE, Rocha R, McMahon EG. Aldosterone target organ protection by eplerenone. Mol Cell Endocrinol. 2004;217:229-238.
28. Gomez-Sanchez EP, Venkataraman MT, Thwaites, et al. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am J Physiol. 1990;258:649-653.
29. Ngarmukos CH, Grekin RJ. Nontradional aspects of aldosterone physiology. Am J Physiol Endocrinol Metab. 2001;281:1122-1127.
30. Birkled D, Heintze U. Salivary secretion rate, buffer capacity and pH. In: Tenouvo I, Jorma O, eds. Human Saliva: Clinical Chemistry and Microbiology. Boca Raton, FL: CRC Press, Inc; 1989:1-24.
31. Gaviao MBD, Engelen L, van der Bilt A. Chewing behaviour and salivary secretion. Eur J Oral Sci. 2004;112:19-24.
32. Olivieri O, Ciacciarelli A, Signorelli D, et al. Aldosterone to renin ratio in a primary care setting: the Busolengo Study. J Clin Endocrinol Metab. 2004;89:4221-4226.
33. Kao CH, Hsieh JF, Tsai SCH, et al. Decreased salivary function in patients with end-stage renal disease requiring hemodialysis. Am J Kidney Dis. 2000;36:1110-1114.
34. Pastorino M, Catalano C, Martorano C, et al. Salivary and lacrimal secretion is reduced in patients with ESRD. Am J Kidney Dis. 2003;42:722-728.
35. Contreras LN, Arregger AL, Persi GG, et al. A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin. Clin Endocrinol. 2004;61:675-682.
36. Falorni A, Laureti S, De Bellis A, et al. Italian Addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency. J Clin Endocrinol Metab. 2004;89:1598-1604.
37. Bastl CP, Hayslett JP. The cellular action of aldosterone in target epithelia. Kidney Int. 1992;42:250-264.
38. Colussi G, Dossi F. Aldosterone and potassium balance in dialysis patients. Nephrol Dial Transplant. 2004;19:1938-1939.
39. Fitzgerald P, Copeland PM. Adrenal disorders. In: Fitzgerald PA, ed. Handbook of Clinical Endocrinology, 2nd ed. Norwalk, CT: Appleton and Lange; 1992:227-287.
40. Ramirez G, Ganguly A, Brueggemeyer CD. Acute effect of captopril on aldosterone secretory responses to endogenous or exogenous adrenocorticotropin. J Clin Endocrinol Metab. 1988;66:46-50.
41. Oster JR, Singer I, Fishman LM. Heparin-induced aldosterone suppression and hyperkalemia. Am J Med. 1995;98:575-586.
42. Schambelan M, Sebastian A, Biglieri EG. Prevalence, pathogenesis and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency. Kidney Int. 1980;17:89-101.
43. Tuck ML, Sambhi MP, Levin L. Hyporeninemic hypoaldosteronism in diabetes mellitus. Studies of the autonomic nervous system's control of renin release. Diabetes. 1979;28:237-241.
44. Findling JW, Buggy BP, Gilson IH, et al. Longitudinal evaluation of adrenocortical function in patients infected with the human immunodeficiency virus. J Clin Endocrinol Metab. 1994;79:1091-1096.
45. Kleeman CR, Levi J, Better O. Kidney and adrenocortical hormones. Nephron. 1975;15:261-278.
46. Letizia C, Mazzaferro S, Morabito S, et al. Response of serum angiotensin converting enzyme, plasma renin activity and plasma aldosterone to conventional dialysis in patients on chronic haemodialysis. Int Urol Nephrol. 1995;27:465-470.
47. Phakdeekitcharoen B, Leelassanguan P. Effects of an ACE inhibitor or angiotensin receptor blocker on potassium in CAPD patients. Am J Kidney Dis. 2004;44:738-746.
48. Hussain S, Dreyfus DE, Marcus RJ, et al. Is spironolactone safe for dialysis patients? Nephrol Dial Transplant. 2003;18:2364-2368.